<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02790762</url>
  </required_header>
  <id_info>
    <org_study_id>HYK-pneumoconiosis</org_study_id>
    <nct_id>NCT02790762</nct_id>
  </id_info>
  <brief_title>Human Umbilical Cord-Mesenchymal Stem Cells for Pneumoconiosis</brief_title>
  <official_title>A Phase I Study of Human Umbilical Cord-Mesenchymal Stem Cells for Pneumoconiosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shenzhen Hornetcorn Bio-technology Company, LTD</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Second Affiliated Hospital of University of South China</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Shenzhen Hornetcorn Bio-technology Company, LTD</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the safety and efficacy of human umbilical cord
      mesenchymal stem cell(hUC-MSC) for Pneumoconiosis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Human umbilical cord mesenchymal stem cells exhibit the potential to differentiate into
      mature cells typical of several tissues, which have been confirmed in in vivo and in vitro
      experiments.

      To investigate the effects of hUC-MSC treatment for Pneumoconiosis, 10 patients with
      Pneumoconiosis will be enrolled and receive 4 times of hUC-MSC transplantation.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>June 2016</start_date>
  <completion_date type="Anticipated">October 2017</completion_date>
  <primary_completion_date type="Anticipated">June 2017</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Severity of adverse events</measure>
    <time_frame>12 months</time_frame>
    <description>According to National Cancer Institute Common Terminology Criteria for Adverse Events（NCI-CTCAE)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Immunological Indicator in serum</measure>
    <time_frame>1, 3 ,6 and 12 months</time_frame>
    <description>Expression levels of various cytokines including interferon-γ、IL-2、IL-1β、IL-4 and transforming growth factor-β1 in serum(U/ml).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The level of ceruloplasmin in serum</measure>
    <time_frame>1, 3 ,6 and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The level of type Ⅲ procollagen peptide in serum</measure>
    <time_frame>1, 3 ,6 and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lung function as assessed by spirometry</measure>
    <time_frame>1, 3 ,6 and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Chest high kilovolt X-ray examination</measure>
    <time_frame>12 month</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Pneumoconiosis</condition>
  <arm_group>
    <arm_group_label>hUC-MSC treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive human umbilical cord mesenchymal stem cells transplantation with a 12 months follow-up.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Human umbilical cord mesenchymal stem cells</intervention_name>
    <description>A single dose of 2×107 hUC-MSC will be implanted to patients by intravenous infusion, and repeated every week for four times.</description>
    <arm_group_label>hUC-MSC treatment</arm_group_label>
    <other_name>hUC-MSC</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The patient who have signed the informed consent document;

          -  Clinical and radiological evidence of liver cirrhosis.

        Exclusion Criteria:

          -  Pregnant women or lactating mothers;

          -  History of neurological disease, head injury or psychiatric disorder;

          -  Patients with positive human immunodeficiency (HIV) at screening indicative of current
             of pass infection;

          -  With malignant tumors;

          -  Abnormal blood coagulation, combine other tumor or special condition;

          -  Patients who had participated in other clinical trials within three months prior to
             this study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Guo Q Li, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>The second Affiliated Hospital of University of Soth China</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jin S Cao, lab master</last_name>
    <phone>+86 0734-53137955</phone>
    <email>CaoJS@hornetcon.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>The second Affiliated Hospital of University of Soth China</name>
      <address>
        <city>Hengyang</city>
        <state>Hunan</state>
        <zip>431224</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Guo Q Li, Professor</last_name>
      <phone>0734-8899939</phone>
      <phone_ext>355</phone_ext>
      <email>LiGQ@126.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>May 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 20, 2016</study_first_submitted>
  <study_first_submitted_qc>May 31, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 6, 2016</study_first_posted>
  <last_update_submitted>May 31, 2016</last_update_submitted>
  <last_update_submitted_qc>May 31, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 6, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>stem cells</keyword>
  <keyword>Mesenchymal Stem Cells</keyword>
  <keyword>Umbilical Cord-Mesenchymal Stem Cells</keyword>
  <keyword>Pneumoconiosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumoconiosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

